The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 178, 7310 -7316
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le, A. V.
Right arrow Articles by Broide, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le, A. V.
Right arrow Articles by Broide, D. H.

Inhibition of Allergen-Induced Airway Remodeling in Smad 3-Deficient Mice1

Annie V. Le*,{dagger}, Jae Youn Cho{dagger}, Marina Miller{dagger}, Shauna McElwain{dagger}, Kirsti Golgotiu{dagger} and David H. Broide2,{dagger}

* Division of Allergy and Immunology, Scripps Clinic and Research Institute, La Jolla, CA 92037; and {dagger} Department of Medicine, University of California, San Diego, La Jolla, CA 92093

Intracellular signaling pathways that converge on Smad 3 are used by both TGF-beta and activin A, key cytokines implicated in the process of fibrogenesis. To determine the role of Smad 3 in allergen-induced airway remodeling, Smad 3-deficient and wild-type (WT) mice were sensitized to OVA and challenged by repetitive administration of OVA for 1 mo. Increased levels of activin A and increased numbers of peribronchial TGF-beta1+ cells were detected in WT and Smad 3-deficient mice following repetitive OVA challenge. Smad 3-deficient mice challenged with OVA had significantly less peribronchial fibrosis (total lung collagen content and trichrome staining), reduced thickness of the peribronchial smooth muscle layer, and reduced epithelial mucus production compared with WT mice. As TGF-beta and Smad 3 signaling are hypothesized to mediate differentiation of fibroblasts to myofibroblasts in vivo, we determined the number of peribronchial myofibroblasts (Col-1+ and {alpha}-smooth muscle actin+) as assessed by double-label immunofluorescence microscopy. Although the number of peribronchial myofibroblasts increased significantly in WT mice following OVA challenge, there was a significant reduction in the number of peribronchial myofibroblasts in OVA-challenged Smad 3-deficient mice. There was no difference in levels of eosinophilic airway inflammation or airway responsiveness in Smad 3-deficient compared with WT mice. These results suggest that Smad 3 signaling is required for allergen-induced airway remodeling, as well as allergen-induced accumulation of myofibroblasts in the airway. However, Smad 3 signaling does not contribute significantly to airway responsiveness.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from National Institutes of Health (T32 AI007469 (to A.V.L. and D.H.B.)) and R01 AI38425) and National Institute of Allergy and Infectious Diseases (U19 AI 70535; to D.H.B.).

2 Address correspondence and reprint requests to Dr. David Broide, University of California, San Diego, Biomedical Sciences Building, Room 5090, 9500 Gilman Drive, La Jolla, CA 92093. E-mail address: dbroide{at}ucsd.edu

3 Abbreviations used in this paper: BALF, bronchoalveolar lavage fluid; AHR, airway responsiveness; Col-1, collagen-1; ECM, extracellular matrix; KO, knockout; MBP, major basic protein; MCh, methacholine; pSmad, phosphorylated Smad; SMA, smooth muscle actin.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. J. Song, J. Y. Cho, S. Y. Lee, M. Miller, P. Rosenthal, P. Soroosh, M. Croft, M. Zhang, A. Varki, and D. H. Broide
Anti-Siglec-F Antibody Reduces Allergen-Induced Eosinophilic Inflammation and Airway Remodeling
J. Immunol., October 15, 2009; 183(8): 5333 - 5341.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Semitekolou, T. Alissafi, M. Aggelakopoulou, E. Kourepini, H. H. Kariyawasam, A. B. Kay, D. S. Robinson, C. M. Lloyd, V. Panoutsakopoulou, and G. Xanthou
Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease
J. Exp. Med., August 3, 2009; 206(8): 1769 - 1785.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. J. Song, M. G. Min, M. Miller, J. Y. Cho, and D. H. Broide
Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen
Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L380 - L387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. H. Lim, J. Y. Cho, D. J. Song, S. Y. Lee, M. Miller, and D. H. Broide
PI3K{gamma}-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling
Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L210 - L219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Fattouh, N. G. Midence, K. Arias, J. R. Johnson, T. D. Walker, S. Goncharova, K. P. Souza, R. C. Gregory Jr., S. Lonning, J. Gauldie, et al.
Transforming Growth Factor-{beta} Regulates House Dust Mite-induced Allergic Airway Inflammation but Not Airway Remodeling
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 593 - 603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.